New research indicates that people who discontinue popular weight-loss injections like Mounjaro or Wegovy may regain lost weight at a significantly accelerated pace than those who halt traditional lifestyle regimens.
Findings released in a leading medical journal demonstrates that while obese people often shed substantial amounts of their total mass while on the medication, the mass comes back at an estimated rate of nearly a kilo each month after stopping.
"People buying such treatments need to be cognizant of the potential of quick weight regain when the therapy ends," cautioned expert Dr. Susan Jebb.
That rate of regain suggests a reversion to starting mass within about a year and a half.
Weighing Treatments
The analysis, which examined 37 of trials involving thousands of patients, contrasted the outcomes of the injectable medications with other pills.
Scientists point out that individuals who lose weight through lifestyle changes alone generally have a more gradual creep back—perhaps 100 grams monthly—post-intervention.
Explaining the Rapid Regain
Nutrition scientists propose the mechanism of the drugs accounts for the accelerated weight return.
The injections copy a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing GLP-1 concentrations far above than normal might result in the system to generate a reduced amount of its endogenous hormone, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this medication results in hunger is uncontrolled, making binge eating a significant risk."
A Chronic Issue?
Health authorities recommend the jabs for people with obesity-related health risks, accompanied by recommended diet and exercise modifications.
A number of clinicians argue that, due to the high risk of weight regain, the therapy might need to be ongoing.
This opinion is reinforced by pharmaceutical companies, who note that the results "underscore the persistent character of excess weight," comparing it to managing diseases like hypertension.
User Testimonies
Users who have discontinued the medication describe a intense resurgence of appetite.
"It felt as if something flipping and I was suddenly ravenous," said an individual.
This difficulty is worsened if users have not adopted sustainable lifestyle or habit changes during therapy.
Growing Use
Figures indicate that a significant number of adults in the UK have used weight-loss jabs in the past year, with interest continuing to grow.
- Use is greater among females than men.
- The middle-aged age group shows the highest level of interest.
- A large proportion obtain the drugs through private healthcare rather than the NHS.
In conclusion, clinicians emphasize that while these medications are potent agents for weight loss, they are not a magic cure and long-term success relies on ongoing behavioural changes.
